Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
N Z Med J ; 131(1484): 13-18, 2018 10 26.
Article in English | MEDLINE | ID: mdl-30359351

ABSTRACT

AIMS: Stroke endovascular clot retrieval (ECR) in patients with large proximal vessel occlusion improves clinical outcomes. We present the New Zealand ECR experience. METHODS: All New Zealand patients treated with ECR since 2011 were included. Patients were considered eligible if they were independent prior to stroke and had proximal intracranial arterial occlusion. RESULTS: Three hundred and twelve patients [136 women, mean (SD) age of 64 (17) years] from 11 district health boards have been treated between March 2011 and April 2018. There were 260 (83%) patients with anterior and 52 (17%) with posterior circulation arterial occlusion. One hundred and ninety-three (62%) patients were pre-treated with intravenous alteplase. The median time from symptom onset to groin puncture was 210 (range 65-985) minutes. Complete or near-complete recanalisation (Thrombolysis in Cerebral Infarction scores of 3 or 2b) was achieved in 260 of 300 (87%) and the National Institutes of Health Stroke Scale score improved from a median of 18 at baseline to 7 at 24 hours. By day 90, 55% of the anterior circulation patients and 40% of the posterior circulation patients were living independently at home. Mortality rates were 20% for anterior circulation patients and 30% for the posterior circulation patients. CONCLUSIONS: This study has shown that stroke endovascular clot retrieval is being provided safely and effectively in New Zealand. However, there remain discrepancies in service provision, and ongoing regional, inter-regional and inter-sector collaboration is essential to implement comprehensive and equitable ECR services across the country.


Subject(s)
Endovascular Procedures , Stroke/therapy , Thrombectomy/methods , Adolescent , Adult , Aged , Aged, 80 and over , Arterial Occlusive Diseases/epidemiology , Arterial Occlusive Diseases/therapy , Brain Ischemia/epidemiology , Brain Ischemia/therapy , Female , Fibrinolytic Agents/therapeutic use , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , New Zealand , Severity of Illness Index , Stroke/epidemiology , Thrombolytic Therapy , Time-to-Treatment/statistics & numerical data , Tissue Plasminogen Activator/therapeutic use , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...